Yi‐Wei Tang
- Infectious Diseases top 0.05%
- Viral gastroenteritis research and epidemiology 43
- Antimicrobial Resistance in Staphylococcus 36
- Clostridium difficile and Clostridium perfringens research 31
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 58
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 38
- Epidemiology top 0.2%
- Respiratory viral infections research 58
- Mycobacterium research and diagnosis 34
- Pneumonia and Respiratory Infections 25
- Endocrinology top 0.5%
- Co-authors
- Charles W. StrattonHongzhou LuDavid H. PersingMichael J. LoeffelholzHaijing LiJonathan E. SchmitzBarney S. GrahamMelissa B. Miller
- Journals
- Journal of Clinical Microbiology (102 papers)Emerging Microbes & Infections (18 papers)Clinical Infectious Diseases (11 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Yi‐Wei Tang
350 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 204
- Infectious Diseases 7.1k
- Clinical Biochemistry 1.6k
- Molecular Medicine 1.1k
- Epidemiology 5.6k
- Endocrinology 760
Countries citing papers authored by Yi‐Wei Tang
This map shows the geographic impact of Yi‐Wei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Wei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Wei Tang more than expected).
Fields of papers citing papers by Yi‐Wei Tang
This network shows the impact of papers produced by Yi‐Wei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Wei Tang. The network helps show where Yi‐Wei Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi‐Wei Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 16 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 2 | |
| 14 | 2018 | 76 | |
| 15 | 2012 | 11 | |
| 16 | 2009 | 84 | |
| 17 | Case report: Staphylococcus gallinarum bacteremia in a patient with chronic hepatitis B virus infection. | 2008 | 15 |
| 18 | 2007 | 12 | |
| 19 | 2005 | 195 | |
| 20 | 1993 | 44 |
About Yi‐Wei Tang
Yi‐Wei Tang is a scholar working on Clinical Biochemistry, Infectious Diseases, Molecular Medicine, Endocrinology and Epidemiology, having authored 364 papers that have together received 15.7k indexed citations. Recurring topics across this work include Respiratory viral infections research (58 papers), Bacterial Identification and Susceptibility Testing (58 papers), Viral gastroenteritis research and epidemiology (43 papers), Antibiotic Resistance in Bacteria (38 papers), Antimicrobial Resistance in Staphylococcus (36 papers), Mycobacterium research and diagnosis (34 papers), Clostridium difficile and Clostridium perfringens research (31 papers) and Pneumonia and Respiratory Infections (25 papers). The work is most often cited by research in Infectious Diseases (7.1k citations), Clinical Biochemistry (1.6k citations), Molecular Medicine (1.1k citations), Epidemiology (5.6k citations) and Endocrinology (760 citations). Yi‐Wei Tang has collaborated with scholars based in United States, China and France. Frequent co-authors include Charles W. Stratton, Hongzhou Lu, David H. Persing, Michael J. Loeffelholz, Haijing Li, Jonathan E. Schmitz, Barney S. Graham, Melissa B. Miller, N. Esther Babady and Gary W. Procop. Their work appears in journals such as Journal of Clinical Microbiology, Emerging Microbes & Infections, Clinical Infectious Diseases, Journal of Molecular Diagnostics and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.